Micafungin: all 49 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver TransplantationNot yet recruitingNCT04728971Phase 4
- Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute LeukemiaCompletedNCT02440178Phase 2Results posted
- Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic SyndromeCompletedNCT01200355Phase 4Results posted
- Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese VolunteersCompletedNCT01090141Phase 4Results posted
- Comparison of Candida Eradication and Serum Cidal Activity of EchinocandinsCompletedNCT00839540Phase 4Results posted
- Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal CandidiasisTerminatedNCT00815516Phase 3Results posted
- Micafungin Versus Amphotercine B in Treatment of Invasive Fungal InfectionCompletedNCT06413056Phase 4
- Antimicrobial Revision in Persistent Febrile NeutropeniaWithdrawnNCT05784844Phase 4
- Evaluate Bioequivalence of Micafungin (50mg/Vial)CompletedNCT05496725Phase 4
- Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological TumorsStatus unknownNCT04738955Phase 4
- Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With MicafunginTerminatedNCT03906916Phase 4
- Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida MeningitisCompletedNCT03421002Phase 2
- Micafungin Pharmacokinetics in Obese PatientsCompletedNCT03102658Phase 4
- Pharmacokinetics of Micafungin During Continuous Venovenous HemofiltrationCompletedNCT02651038Phase 4
- Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus SppTerminatedNCT02646800Phase 4
- Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive AspergillosisTerminatedNCT02646774Phase 4
- Fluconazole Versus Micafungin in Neonates With CandidiasisCompletedNCT02145832Phase 2/3
- A Pharmacokinetic Study of Pediatric Micafungin ProphylaxisTerminatedNCT02057289Phase 1
- A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or CandidemiaTerminatedNCT01982071Phase 4
- Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant RecipientsStatus unknownNCT01974375Phase 3
- Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD)CompletedNCT01888458Phase 2
- Empirical Antifungal Treatment in ICUSCompletedNCT01773876Phase 3
- Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane OxygenationCompletedNCT01666769Phase 1
- Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell TransplantationStatus unknownNCT01417169Phase 2
- Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological DiseasesCompletedNCT01344681Phase 2
- Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive AspergillosisWithdrawnNCT01207128Phase 2
- Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell TransplantationStatus unknownNCT01135589Phase 4
- A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical SubjectsCompletedNCT01122368Phase 2
- Liver Transplant European Study Into the Prevention of Fungal InfectionCompletedNCT01058174Phase 3
- Alternate Day Micafungin: A PK Study in Pediatric PatientsCompletedNCT00842504Phase 1
- An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in NeonatesCompletedNCT00818584Phase 1
- A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal InfectionsCompletedNCT00794703Phase 3
- Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal CandidiasisCompletedNCT00666185Phase 3
- Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal CandidiasisCompletedNCT00665639Phase 3
- Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00608335Phase 1
- Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00607763Phase 1
- A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell TransplantCompletedNCT00606268Phase 1
- A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive AspergillosisWithdrawnNCT00423163Phase 4
- Micafungin Salvage Mono-therapy in Invasive AspergillosisTerminatedNCT00376337Phase 2
- Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic PatientsWithdrawnNCT00304772Phase 4
- Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and CandidemiaCompletedNCT00189709Phase 3
- Micafungin Versus AmBisome in Invasive Candidiasis and CandidemiaCompletedNCT00106288Phase 3
- Study of Micafungin in Patients With Invasive Candidiasis or CandidemiaCompletedNCT00105144Phase 3
- Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICUTerminatedNCT00048750Phase 3
- Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for AspergillosisTerminatedNCT00047827Phase 2
- Study of FK463 in the Treatment of Candidemia or Invasive CandidiasisCompletedNCT00036179Phase 2
- Study of FK463 for the Treatment of Invasive AspergillosisCompletedNCT00036166Phase 2
- Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant PatientsCompletedNCT00001937Phase 3
- Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and NeutropeniaCompletedNCT00001790Phase 1